Evotec competitorsClear all

Evotec's top competitors include Inovio Pharmaceuticals, Regenxbio, Sangamo BioSciences and ICAgen.
Evotec
Evotec
Evotec is a drug discovery alliance and development partnership company.
Inovio Pharmaceuticals
Inovio Pharmaceuticals
Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.
Regenxbio
Regenxbio
Regenxbio develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Sangamo BioSciences
Sangamo BioSciences
Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.
ICAgen
ICAgen
ICAgen is a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.
Founding Date
Founding Date
1993
Founding Date
1979
Founding Date
2009
Founding Date
1995
Founding Date
1992
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
Hamburg, DE HQ
Orth An Der Donau, AT
Lyon, FR
Toulouse, FR
Göttingen, DE
Köln, DE
Planegg, DE
see more
Locations
Plymouth Meeting, US HQ
San Diego, US
San Diego, US
Locations
Rockville, US HQ
Locations
Richmond, US HQ
Locations
Durham, US HQ
Oro Valley, US
Employees
Employees
2,75622% increase
Employees
2811% increase
Employees
25734% increase
Employees
30266% increase
Employees
668% decrease
Valuation ($)
Valuation ($)
4.1 b
Valuation ($)
1.9 b
Valuation ($)
1.4 b
Valuation ($)
1.5 b
Valuation ($)
N/A
Twitter followers
Twitter followers
2 k
Twitter followers
10.1 k
Twitter followers
1.1 k
Twitter followers
N/A
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
43
Number of tweets (last 30 days)
17
Number of tweets (last 30 days)
8
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
157.8
Average likes per tweet (last 30 days)
5.4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
316806
Alexa Website Rank
181842
Alexa Website Rank
476378
Alexa Website Rank
179299
Alexa Website Rank
318125
Employee Rating
Employee Rating
3.1
Employee Rating
3.6
Employee Rating
4.1
Employee Rating
3.8
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$4.1m (FY, 2019)
Revenue (est.)
$35.2m (FY, 2019)
Revenue (est.)
$102.4m (FY, 2019)
Revenue (est.)
$13.6m (FY, 2018)
Net income
Net income
N/A
Net income
($120.6m) (FY, 2019)
Net income
($94.7m) (FY, 2019)
Net income
($95.2m) (FY, 2019)
Net income
($13m) (FY, 2018)

Funding

Total funding raised
Total funding raised
$ 160m
Total funding raised
$ 202.6m
Total funding raised
$ 118.9m
Total funding raised
$ 74.2m
Total funding raised
$ 6.1m
For sources of this data, please see the company profile

View company profiles

Inovio Pharmaceuticals
HQ
Plymouth Meeting, US
Employees
281↑ 1% increase

Inovio Pharmaceuticals is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid immunotherapies and vaccines.

View company
Regenxbio
HQ
Rockville, US
Employees
257↑ 34% increase

Regenxbio develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

View company
Sangamo BioSciences
HQ
Richmond, US
Employees
302

Sangamo researches, develops and commercializes engineered DNA-binding proteins for the development of novel therapeutic strategies.

View company
ICAgen
HQ
Durham, US
Employees
66↓ 8% decrease

ICAgen is a biopharmaceutical company, develops novel orally-administered small molecule drugs that modulate ion channel targets.

View company